Cargando…
Germline CDH1 mutations in bilateral lobular carcinoma in situ
BACKGROUND: Invasive lobular breast cancer (ILC) and lobular carcinoma in situ (LCIS) are characterised by loss of E-cadherin expression. However germline CDH1 mutations are rare in cases of ILC with no family history of hereditary diffuse gastric cancer (HDGC) and have not been described in women w...
Autores principales: | Petridis, C, Shinomiya, I, Kohut, K, Gorman, P, Caneppele, M, Shah, V, Troy, M, Pinder, S E, Hanby, A, Tomlinson, I, Trembath, R C, Roylance, R, Simpson, M A, Sawyer, E J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929874/ https://www.ncbi.nlm.nih.gov/pubmed/24366306 http://dx.doi.org/10.1038/bjc.2013.792 |
Ejemplares similares
-
Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010) -
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
por: Timbres, Jasmine, et al.
Publicado: (2023) -
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression
por: Shah, Vandna, et al.
Publicado: (2017) -
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
por: Schrader, K A, et al.
Publicado: (2010) -
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
por: Petridis, Christos, et al.
Publicado: (2019)